Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Kevin P Callahan, PhD, Cheryl Corbett, Steven Jacob, Mohammad Minhajuddin, PhD, Eleni D Lagadinou, MD/PhD, Randall M Rossi, MS, Valerie Gross, Marlene Balys, Fred Hagen, PhD, Alison J Frontier, PhD, Craig T. Jordan, PhD

Blood (2012) 120 (21): 1338.

https://doi.org/10.1182/blood.V120.21.1338.1338

Published: 2012

Journal Articles

Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Eleni D Lagadinou, MD/PhD, Alexander Sach, BS, Kevin P Callahan, PhD, Randall M. Rossi, MS, Sarah Neering, MS, Shanshan Pei, BS, Kristen O'Dwyer, MD, Jane L. Liesveld, MD, Paul S. Brookes, PhD, Michael W. Becker, MD, Craig T. Jordan, PhD

Blood (2012) 120 (21): 206.

https://doi.org/10.1182/blood.V120.21.206.206

Published: 2012

Journal Articles

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

Eleni D. Lagadinou, MD, PhD, Dimitra Kokkinou, Elena Siapati, PhD, George Vassilopoulos, MD, PhD, Craig T. Jordan, PhD, Alexandros Spyridonidis, MD, PhD

Blood (2010) 116 (21): 1580.

https://doi.org/10.1182/blood.V116.21.1580.1580

Published: 2010

Journal Articles

c-Jun N-Terminal Kinase (JNK) Activation Failure Confers a New Mechanism of Anthracycline Resistance in Acute Myeloid Leukemia (AML).

Eleni D. Lagadinou, MD, Panagiotis G. Ziros, PhD, Olga A. Tsopra, MD, Kostas Dimas, PhD, Panagiotis Pantazis, PhD, Alexandros Spyridonidis, MD, PhD, Nicholas C. Zoumbos, MD, PhD

Blood (2007) 110 (11): 2377.

https://doi.org/10.1182/blood.V110.11.2377.2377

Published: 2007

Journal Articles

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Eleni D. Lagadinou, Panos Ziros, Olga Tsopra, Eleni Thanopoulou, Alexandra Kouraklis, Marina Karakantza, Nicholas C. Zoumbos

Blood (2006) 108 (11): 4379.

https://doi.org/10.1182/blood.V108.11.4379.4379

Published: 2006

NARROW

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

c-Jun N-Terminal Kinase (JNK) Activation Failure Confers a New Mechanism of Anthracycline Resistance in Acute Myeloid Leukemia (AML).

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Email alerts

ASH Publications

American Society of Hematology

Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Isolation and Functional Characterization of a Novel “Oxidative State – low” Leukemic Population with Stem Cell Properties and Potential Resistance to Chemotherapy In Acute Myeloid Leukemia.

c-Jun N-Terminal Kinase (JNK) Activation Failure Confers a New Mechanism of Anthracycline Resistance in Acute Myeloid Leukemia (AML).

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only